11β-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension

European Heart Journal

Volumn 26, Issue 5, 2005, Pages 498-504

  Glorioso, Nicola ^a   Filigheddu, Fabiana ^a   Parpaglia, Paolo Pinna ^b   Soro, Aldo ^a   Troffa, Chiara ^a   Argiolas, Giuseppe ^a   Mulatero, Paolo ^c  

^a UNIVERSITY OF SASSARI   (Italy)

^b Neurology Unit   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

11 Hydroxysteroid dehydrogenase; Blood pressure; Cardiac mass; Glucocorticoids; Mineralocorticoids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ANGIOTENSIN; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; CORTODOXONE; DRUG DERIVATIVE; RENIN; TETRAHYDRO 11 DEOXYCORTISOL; TETRAHYDRO-11-DEOXYCORTISOL; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

ADULT; ALDOSTERONE URINE LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE MASS; HORMONAL REGULATION; HUMAN; HYDROCORTISONE URINE LEVEL; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET ORGAN; COHORT ANALYSIS; ECHOCARDIOGRAPHY; ENZYMOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ALDOSTERONE; BLOOD PRESSURE; COHORT STUDIES; CORTODOXONE; ECHOCARDIOGRAPHY; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RENIN; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

EID: 14644408734     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi070     Document Type: Article

References (47)

1. Arriza JL, Weinberger C, Cerelli G et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268-275.
2. Funder JW, Pearce PT, Smith R et al. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583-585.
3. Monder C, White PC. 11β-hydroxysteroid dehydrogenase. Vitam Horm 1993;47:187-271.
4. Ulick S, Levine LS, Gunczler P et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979;49:757-764.
5. Stewart PM, Corrie JE, Shacktelon CH et al. Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 1988;82:340-349.
6. Li A, Tedde R, Krozowski ZS et al. Molecular basis for hypertension in the type II variant of apparent mineralocorticoid excess. Am J Hum Genet 1998;63:370-379.
7. Walker BR, Stewart PM, Shackleton CH et al. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol 1993;39:221-227.
8. Soro A, Ingram MC, Tonolo G et al. Evidence of coexisting changes in the 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension 1995;25:67-70.
9. Agarwal AK, Giacchetti G, Lavery G et al. CA-Repeat polymorphism in intron 1 of HSD11B2. Effects on gene expression and salt sensitivity. Hypertension 2000;36:187-194.
10. Lovati E, Ferrad P, Dick B et al. Molecular basis of human salt-sensitivity: the role of the 11β-hydroxysteroid dehydrogenase typ. 2. J Clin Endocrinol Metab 1999;84:3745-3749.
11. Verdecchia P, Porcellati C, Reboldi G et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001;104:2039-2044.
12. Savage DD, Levy D, Dannenberg AL et al. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). Am J Cardiol 1990;65:371-376.
13. Levy D, Garrison RJ, Savage DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
14. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994;23:869-877.
15. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
16. El-Gharbawy AH, Nadig VS, Kotchen JM et al. Arterial pressure, left ventricular mass and aldosterone in essential hypertension. Hypertension 2001;37:845-850.
17. Rossi GP, Di Bello V, Ganzaroli C et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002;40:23-27.
18. Goldkorn R, Yurenev A, Blumenfeld J et al. Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension. Am J Hypertens 2002;15:340-345.
19. Lombes M, Alfaidy N, Eugene E et al. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 1995;92:175-182.
20. Slight SH, Ganjam VK, Gomez-Sanchez CE et al. High affinity NAD(+)-dependent 11 beta-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 1996;28:781-787.
21. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2446.
22. Ambrosio GB, Bugaro L, Gabaldo S et al. Blood pressure and its spontaneous variations in a northern Italian population. Clin Sci Mol Med Suppl 1976;3:669s-671s.
23. Preibisz JJ, Sealey JE, Aceto RM et al. Plasma renin activity measurements: an update. Cardiovasc Rev Rep 1982;3:787-804.
24. Sahn DJ, DeMaria A, Kisslo J et al. Committee on M-Mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-Mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
25. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
26. de Simone G, Daniels SR, Devereux RB et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20:1251-1260.
27. Wachtell K, Bella JN, Liebson PR et al. Impact of different partition values on prevatences of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE study. Hypertension 2000;35:6-12.
28. Verdecchia P, Porcellati C, Zampi I et al. Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses. Am J Cardiol 1994;73:247-252.
29. Ferrari P, Sansonnens A, Dick B et al. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension 2001;38:1330-1336.
30. Roman MJ, Pickering TG, Pini R et al. Prevalence and determinants of cardiac and vascular hypertrophy in hypertension. Hypertension 1995;26:369-373.
31. Duprez DA, Bauwens FR, De Buyzere ML et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1993;71:17A-20A.
32. Harrap SB, Dominiczak AF, Fraser R et al. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation 1996;93:1148-1154.
33. Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19:589-601.
34. He FJ, Markandu ND, MacGregor GA. Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension 2001; 38:321-325.
35. Palermo M, Delitala G, Mantero F et al. Congenital Deficiency of 11β hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone. J Endocrinol Invest 2001;24:17-23.
36. Best R, Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol 1997;47:231-236.
37. Schunkert H, Hense HW, Muscholl M et al. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 1997;77:24-31.
38. Sato A, Suzuky H, Murakami M et al. Glucocorticoid increases angiotensin II type I receptor and its gene expression. Hypertension 1994;23:25-30.
39. Brem AS, Bina RB, Fitzpatrick C et al. Glucocorticoid metabolism in proximal tubules modulates angiotensin II-induced electrolyte transport. Proc Soc Exp Biol Med 1999;221:111-117.
40. Fallo F, Budano S, Sonino N et al. Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens 1994;8:509-513.
41. Muiesan ML, Lupia M, Salvetti M et al. Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol 2003;41:2275-2279.
42. Vasan RS, Evans JC, Larson MG et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004;351:33-41.
43. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
44. Pitt B, Remme W, Zannad F et al. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321.
45. Schmieder RE, Messerli FH, Garavaglia GE et al. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988;78:951-956.
46. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36-to-37 years. Focus on lifestyle and salt intake. Circulation 1994;89:1041-1050.
47. Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-536.